Fact CheckerSign in

NCT06325202Recruiting

Closed Loop and Education for Hypoglycemia Awareness Restoration

Closed Loop and Education for Hypoglycemia Awareness Restoration (CLEAR), Conducted by the Impaired Awareness of Hypoglycemia Consortium (IAHC)

Source: ClinicalTrials.gov · Last updated 30 Oct 2026

Brief summary (registry, in English)

The purpose of the CLEAR study is to determine the effect on counterregulatory responses (CRR) of intervening (by attempting to strictly avoid hypoglycemia) to improve awareness of hypoglycemic symptoms among adults with type 1 diabetes (T1D) who have impaired awareness of hypoglycemia (IAH). IAH affects 20-25% of adults with T1D, and rises with increasing duration of T1D.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
324 (estimated)
First submitted
5 Mar 2024
Start date
3 Oct 2025
Primary completion date
31 Dec 2029
Lead sponsor
Milton S. Hershey Medical Center
NCT number
NCT06325202

What you commit to

  • Study type: Interventional
  • Planned participants: 324
  • From 3 Oct 2025 to the primary completion date, 31 Dec 2029
  • 8 sites in 3 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Super-physiologic exposure to steroids within one month of enrollment

Other illness

  • Medical conditions that limit participation in study activities, as determined by the PI (including but not limited to cognitive dysfunction, reduced hearing, reduced vision, cancer under active treatment, untreated angina, organ failure)
  • Active alcohol or drug abuse (as defined by DSM criteria of either 1) recurrent use of alcohol/drugs resulting in a failure to fulfill major role obligations at work, school, or home, 2) recurrent alcohol/drug use in situations in which it is physically hazardous, or 3) recurrent alcohol or drug-related legal problems)
  • Seizure disorder unrelated to hypoglycemia associated seizures, unless documented seizure-free for \>12 months and on a stable regimen of anti-convulsant therapy
  • Skin conditions that would preclude the use of a CGM
  • History of bariatric surgery that irreversibly alters gut innervation and structure
  • Medical condition that requires intermittent or continuous use of glucocorticoids at greater than physiological replacement doses
  • Hospitalization for mental illness in last year

Lab values

  • eGFR \< 45 mL/min/1.73 m2
  • Hyper- or hypokalemia (serum potassium \>5.5 or \<3.5 mmol/L)\*
  • Hemoglobin \< 10 g/dL\*
  • Liver transaminases \> 3 times the upper limit of normal\*
  • History of adrenalectomy
    • At discretion of the PI, laboratory tests may be repeated once. If the participant is not eligible after the second attempt, then the participant. The participant may be screened again.

Other

  • Social determinants of health that limit participation in study activities, as determined by the PI (including but not limited to homelessness, food insecurity, inadequate social support)
  • Pregnancy, plan for pregnancy, or breast feeding
  • Abnormal thyroid function tests of clinical significance, as determined by PI\*

Who the study is looking for

  • Clinical diagnosis of type 1 diabetes
  • Gold Score or Clarke Score ≥ 4 (highly associated with IAH)
  • Random non-fasting C-peptide \< 200 pmol/L
  • Diabetes duration ≥ 10 years
  • HbA1c \< 10.5%
  • Total Daily Insulin Dose of \< 1 unit/kg
  • Ability to read and speak English (because validated non-English versions of the cognitive tests and the educational interventions are not available)

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (8)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Melbourne
Coordinator of this site? Confirm its status
FitzroyAustraliaRecruiting
University of Leicester
Coordinator of this site? Confirm its status
LeicesterUnited KingdomRecruiting
University of Sheffield
Coordinator of this site? Confirm its status
SheffieldUnited KingdomRecruiting
University of California San Diego
Coordinator of this site? Confirm its status
La JollaUnited StatesRecruiting
University of Kentucky
Coordinator of this site? Confirm its status
LexingtonUnited StatesRecruiting
University of Minnesota
Coordinator of this site? Confirm its status
MinneapolisUnited StatesRecruiting
AdventHealth
Coordinator of this site? Confirm its status
OrlandoUnited StatesRecruiting
University of Pennsylvania
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.